Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depression

Alvir, 1993, Clozapine-induced agranulocytosis incidence and risk factors in the United States, New Eng J Med, 329, 162, 10.1056/NEJM199307153290303 American Psychiatric Association, 1987 Avery, 1979, Depression treated with imipramine and ECT: The deCarolis study reconsidered, Am J Psychiatry, 136, 559, 10.1176/ajp.1979.136.4b.559 Ayd, 1983, Treatment-resistant depression, Int Drug Ther Newsletter, 18, 25 Casey, 1989, Clozapine: Neuroleptic-induced EPS and tardive dyskinesia, Psychopharmacology, 99, S47, 10.1007/BF00442559 Chacko, 1993, Clozapine use in diffuse Lewy body disease, J Neuropsychiatry Clin Neurosci, 5, 206, 10.1176/jnp.5.2.206 Claghorn, 1987, The risks and benefits of clozapine versus chlorpromazine, J Clin Psychopharmacol, 7, 377, 10.1097/00004714-198712000-00002 Dassa, 1993, Clozapine in treatment of psychotic refractory depression, Br J Psychiatry, 163, 822, 10.1192/bjp.163.6.822 Davis, 1976, Tardive dyskinesia and depressive illness, Psychopharmacol Commun, 2, 125 Endicott, 1978, A diagnostic interview: The schedule for affective disorders and schizophrenia, Arch Gen Psychiatry, 35, 837, 10.1001/archpsyc.1978.01770310043002 Farde, 1992, Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine, Arch Gen Psychiatry, 49, 538, 10.1001/archpsyc.1992.01820070032005 Glassman, 1975, Depression, delusions, and drug response, Am J Psychiatry, 132, 716, 10.1176/ajp.132.7.716 Gonzalez, 1992, Clozapine for refractory psychosis, J Am Acad Child Adolesc Psychiatry, 31, 1169, 10.1097/00004583-199211000-00034 Hamilton, 1960, A rating scale for depression, J Neurol Neurosurg Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 Hasegawa, 1993, Relationship between clinical efficacy and clozapine plasma concentrations in schizophrenia: Effect of smoking, J Clin Psychopharmacol, 13, 383, 10.1097/00004714-199312000-00003 Hordern, 1983, Amitriptyline in depressive states, Br J Psychiatry, 109, 815, 10.1192/bjp.109.463.815 Imperato, 1991, The effect of clozapine and fluperlapine on the in vivo release and metabolism of dopamine in striatum and in the frontal cortex of freely-moving rats, Psychopharmacol Bull, 25, 383 Kane, 1988, Clozapine for the treatment-resistant schizophrenic: A double blind comparison with chlorpromazine, Am J Psychiatry, 45, 789 Kaskey, 1980, Drug treatment in delusional depression, Psychiatry Res, 1, 267, 10.1016/0165-1781(80)90019-0 Klik, 1976, Experience with clozapine in psychiatric home practice, Csek Psychiatrie, 72, 197 Kogan, 1974, New drugs in the treatment of nervous and mental disease, Reports of Leningrad Bechterev Psychoneurological Research Institute, 4041 Kroessler, 1985, Relative efficacy rates for therapies of delusional depression, Convulsive Ther, 1, 173 Lieberman, 1994, Clinical effects of clozapine in chronic schizophrenia: Response to treatment and predictors of outcome, Am J Psychiatry, 151, 1744, 10.1176/ajp.151.12.1744 Matsubara, 1989, Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex, Life Sci, 45, 1397, 10.1016/0024-3205(89)90027-1 McClelland, 1986, Mortality and facial dystonia, Br J Psychiatry, 148, 310, 10.1192/bjp.148.3.310 McElroy, 1991, Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia, J Clin Psychiatry, 52, 411 Meltzer, 1992, Treatment of the neuroleptic non-responsive schizophrenic patient, Schizophr Bull, 18, 515, 10.1093/schbul/18.3.515 Meltzer, 1991, The mechanism of action of novel antipsychotic drugs, Schizophr Bull, 17, 263, 10.1093/schbul/17.2.263 Meltzer, 1989, A prospective study of clozapine in treatment-resistant patients: I. Preliminary report, Psychopharmacology, 99, S68, 10.1007/BF00442563 Meltzer, 1995, Emerging clinical uses of clozapine, 6, 187 Mikuni, 1984, Reduction of serotonin-2 receptors in rat cerebral cortex after subchronic administration of imipramine, chlorpromazine, and the combination thereof, Life Sci, 34, 87, 10.1016/0024-3205(84)90334-5 Naber, 1992, Clinical management of clozapine patients in relation to efficacy and side-effects, Br J Psychiatry, 160, 54, 10.1192/S0007125000296931 Nahunek, 1973, Clinical experience with clozapine in endogenous depression, Activ Nerv Sup (Praha), 15, 111 Nahunek, 1975, Klinicke zkusenostis clozapinem, Csek Psychiatrie, 71, 11 Nelson, 1978, Delusional unipolar depression, Arch Gen Psychiatry, 35, 1321, 10.1001/archpsyc.1978.01770350047004 Nierenberg, 1991, Methodological considerations for the study of treatment-resistant depression, 1 Overall, 1962, The Brief Psychiatric Rating Scale, Psychol Reports, 10, 799, 10.2466/pr0.1962.10.3.799 Parsa, 1991, Effect of clozapine on psychotic depression and parkinsonism, J Clin Psychopharmacol, 11, 330, 10.1097/00004714-199110000-00019 Parsa, 1993, Psychiatric manifestations of olivo-ponto-cerebellar atrophy and treatment with clozapine, Int J Psychiatr Med, 23, 149, 10.2190/PNR2-PW5Y-KF07-H5BE Roose, 1986, Tricyclic responders: Phenomenology and treatment, Am J Psychiatry, 143, 345, 10.1176/ajp.143.3.345 Rosenbaum, 1977, Tardive dyskinesia: Relationship with a primary affective disorder, Dis Nerv Syst, 38, 423 Roth, 1992, Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors, J Pharmacol Exp Ther, 260, 1361 Roth, 1994, Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine6 (5HT6) and 5-hydroxytryptamine7 (5-HT7) receptors, J Pharmacol Exp Ther, 268, 1406 Roubicek, 1977, EEG profile and behavioral changes after a single dose of clozapine in normals and schizophrenics, Biol Psychiatry, 12, 613 Rush, 1982, Depression as a risk factor in tardive dyskinesia, Biol Psychiatry, 17, 387 Sajatovic, 1991, Clozapine treatment of psychiatric symptoms resistant to neuroleptic treatment in patients with Huntington's chorea, Neurology, 41, 156, 10.1212/WNL.41.1.156 Suppes, 1992, Clozapine in the treatment of dysphoric mania, Biol Psychiatry, 32, 270, 10.1016/0006-3223(92)90108-C Tanda, 1994, Increase of extracellular dopamine in the prefrontal cortex: A trait of drugs with antidepressant potential?, Psychopharmacology, 115, 285, 10.1007/BF02244785 Wagner, 1988, Drug therapy strategies for treatment-resistant depression, Psychopharmacol Bull, 24, 69 Wellner, 1993, Does clozapine cause neuroleptic-malignant syndrome?, J Clin Psychopharmacol, 54, 70 Yassa, 1984, Tardive dyskinesia and the primary psychiatric diagnosis, Psychosomatics, 25, 135, 10.1016/S0033-3182(84)73083-0